CHA Vaccine Institute is developing a mixed vaccine that can offer protection against both COVID-19 and influenza as part of its efforts to prevent multiple diseases with a single dose, the biotech company said Tuesday. The company said it has been developing the mixed vaccine using its own immunity-enhancing platform, L-pampo, to increase immunity against both COVID-19 and influenza.
What is it then that he is particularly worried about? i think it s this broader question about inequality. vaccine inequality. and huge differences in uptake in different countries with the developed, richer nations moving ahead with boosters and first and second doses in some countries really not being available to anything like the majority of the population or they have not been jabbed so far. i think with omicron which has emerged in southern africa as you say, the evidence there from south africa is that it caused quite a sharp spike and the hospitalisations but then it receded quite quickly and people have looked at that and said, well, it s not quite as bad as delta and of course south africa has a younger population and there are different factors, but the evidence from the uk and more has emerged from scientific
Plus, leaving las vegas. top tech firms give the consumer electronics show a miss as covid cases surge. we start with the row over vaccine inequality. should rich nations be doing more to get people in poorer countries vaccinated against covid? well, on thursday, a group of 65 global investment funds weighed into the debate. they want the bonuses of drug company bosses to be linked to a fairer distribution of vaccines around the world. and they are threatening to vote against ceo pay